“First and foremost we want to protect those vulnerable populations that haven’t been adequately protected by the vaccine,” said Menelas Pangaloa, AstraZeneca’s head of research and development. “But ultimately it will be up to health authorities to work out who they choose to immunize.”
Prepare Now Before its too Late
Discover where products are available & compare prices
